EMEA-000828-PIP01-09-M09 - paediatric investigation plan
empagliflozin
PIP
Human
Boehringer Ingelheim International GmbH
E-mail: COMMSPaediatrics@boehringer-ingelheim.com
Tel. +49 (0)6132 77 8271